Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.24M Buy
44,300
+32,200
+266% +$3.72M ﹤0.01% 2052
2026
Q1
$1.45M Sell
12,100
-10,100
-45% -$1.32M ﹤0.01% 2895
2025
Q4
$3.02M Buy
22,200
+9,000
+68% +$1.29M ﹤0.01% 2101
2025
Q3
$1.95M Buy
+13,200
New +$1.83M ﹤0.01% 2244
2025
Q2
Sell
-10,900
Closed -$1.3M 3657
2025
Q1
$1.3M Sell
10,900
-2,300
-17% -$285K ﹤0.01% 2095
2024
Q4
$1.53M Buy
+13,200
New +$1.67M ﹤0.01% 2063

Other funds holding XYL

IMC Chicago's XYL Position: Q2 2026 in Review

IMC Chicago increased its Xylem (XYL) stake by 738% in Q2 2026, buying an estimated $2.94M and bringing the position to 28,912 shares worth $3.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2513.

IMC Chicago first reported a position in XYL in Q1 2026 and has held it in 2 quarters since. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • IMC Chicago held 28,912 shares of Xylem worth $3.42M as of Q2 2026.
  • IMC Chicago bought 25,460 Xylem shares in Q2 2026, an estimated $2.94M.
  • Xylem made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #2513 holding.
  • IMC Chicago first reported a position in Xylem in Q1 2026 and has held it in 2 quarters since.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.